EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Evaluating the innovative potential of the global antibacterial pipeline

Ursula Theuretzbacher

Clinical Microbiology and Infection · 2025-06 · 31 (6) · 903-909

DOI: 10.1016/j.cmi.2023.09.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology and Infection, 2025-06. Verfasst von Ursula Theuretzbacher. Beteiligte Einrichtung: Center for Anti-Infective Agents, Vienna, Austria. Electronic address: utheuretzbacher@cefaia.com. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Discovery, Bacteria, Bacterial Infections. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDrug DiscoveryBacteriaBacterial InfectionsHumansGlobal HealthDrug Resistance, BacterialDrug Development

Stichwörter der Autor:innen

Antibacterial drug developmentAntibacterial pipelineAntibioticsInnovationResistance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Anti-Infective Agents, Vienna, Austria. Electronic address: utheuretzbacher@cefaia.com.

Zitieren

APA

Theuretzbacher, U. (2025). Evaluating the innovative potential of the global antibacterial pipeline. Clinical Microbiology and Infection, 31(6), 903-909. https://doi.org/10.1016/j.cmi.2023.09.024

Vancouver

Theuretzbacher U. Evaluating the innovative potential of the global antibacterial pipeline. Clinical Microbiology and Infection. 2025;31(6):903-909. doi:10.1016/j.cmi.2023.09.024

BibTeX
@article{Theuretzbacher2025,
  author = {Theuretzbacher, Ursula},
  title = {Evaluating the innovative potential of the global antibacterial pipeline},
  journal = {Clinical Microbiology and Infection},
  year = {2025},
  volume = {31},
  number = {6},
  pages = {903--909},
  doi = {10.1016/j.cmi.2023.09.024}
}
Kostenlos starten →